| 2024/04/26 08:02:04 | |
|---|---|
| Price | |
| 283.90 EUR | |
| Difference | -1.11% (-3.20) |
General attributes
| ISIN | DE0007165631 |
| Symbol | SRT3 |
| Exchange | Munich |
| Currency | EUR |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 17,417 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 283.90 EUR |
| High | 283.90 EUR |
| Low | 283.90 EUR |
| Close (prev. day) | 287.10 EUR |
| VWAP | 287.10 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | 38 |
| Related Options | - |
PDF Downloads
| Company report: SARTORIUS AG VZ |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/04/26 08:02:04 | |
|---|---|
| Price | |
| 283.90 EUR | |
| Difference | -1.11% (-3.20) |
General attributes
| ISIN | DE0007165631 |
| Symbol | SRT3 |
| Exchange | Munich |
| Currency | EUR |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 17,417 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 283.90 EUR |
| High | 283.90 EUR |
| Low | 283.90 EUR |
| Close (prev. day) | 287.10 EUR |
| VWAP | 287.10 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +29.52% | -18.82% | -38.18% |
| Perf (abs.) | +64.70 | -65.80 | -175.30 |
| Beta | 1.65 | 1.88 | 1.06 |
| Volatility | 48.11 | 46.77 | 46.38 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 285.38 EUR (22) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 338.39 EUR (12) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 331.08 EUR (8) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 322.67 EUR (13) |
| YTD High | date | 379.10 EUR (2024/03/25) |
| YTD Low | date | 270.90 EUR (2024/04/19) |
| 52 Weeks High | date | 379.10 EUR (2024/03/25) |
| 52 Weeks Low | date | 218.40 EUR (2023/10/31) |
All listings for SARTORIUS AG VZ
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/04/26 | 17:35 | 290.20 EUR | 22.74 | 2,623 |
| Vienna Stock Exchange | 2024/04/26 | 17:32 | 292.00 EUR | 0.01 | 3 |
| Tradegate | 2024/04/26 | 22:26 | 290.50 EUR | 2.16 | 139 |
| Stuttgart | 2024/04/26 | 21:59 | 289.50 EUR | 0.10 | 167 |
| SIX Swiss Exchange | 2019/04/05 | 17:30 | 179.50 CHF | 0.00 | 3 |
| Munich | 2024/04/26 | 08:02 | 283.90 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2024/04/26 | 17:30 | 289.40 EUR | 0.00 | 2 |
| Hanover | 2024/04/26 | 08:16 | 281.90 EUR | 0.00 | 3 |
| Hamburg | 2024/04/26 | 08:16 | 281.90 EUR | 0.00 | 3 |
| Frankfurt | 2024/04/26 | 13:29 | 289.60 EUR | 0.00 | 1 |
| FINRA other OTC Issues | 2024/04/26 | 16:15 | 303.68 USD | 0.09 | 1 |
| Euronext Milan MTF Trading After Hours | 2024/04/26 | 17:44 | 291.60 EUR | 0.00 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/04/26 | 17:44 | 291.60 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/26 | 19:32 | 289.10 EUR | 0.00 | 7 |
| Berlin | 2024/04/26 | 08:02 | 281.90 EUR | 0.00 | 2 |
Company Logo
Contact Details
| SARTORIUS AG |
| - - |
| Otto-Brenner-Strasse 20 - 37079 Goettingen |
| Telefon: +49-551-308-0 |
| Fax: +49-551-308-3289 |
| E-mail: info@sartorius.com |
PDF Downloads
| Company report: SARTORIUS AG VZ | |
Company Profile
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany. |
Members of Management Board
| Joachim Kreuzburg | Chairman of Managing Board |
| Alexandra Gatzemeyer | Member of Executive Committee |
| Rene Faber | Member of Executive Committee |
Board of directors
| Lothar Kappich | Chairman of Supervisory Board |
| Daniela Favoccia | Member of Supervisory Board |
| David Ebsworth | Member of Supervisory Board |
| Klaus Rüdiger Trützschler | Member of Supervisory Board |
| Annette Becker | Member of Supervisory Board |
| Dietmar Müller | Member of Supervisory Board |
| Frank Riemensperger | Member of Supervisory Board |
| Hermann Jens Ritzau | Member of Supervisory Board |
| Ilke Panzer | Member of Supervisory Board |
| Manfred Zaffke | Member of Supervisory Board |
| Petra Kirchhoff | Member of Supervisory Board |
| Sabrina Wirth | Member of Supervisory Board |